
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is an innovative treatment designed for patients with peritoneal carcinomatosis, a condition where cancer spreads throughout the abdominal cavity. Traditional chemotherapy often struggles to reach tumors effectively in the peritoneum, limiting its impact. PIPAC addresses this challenge by delivering chemotherapy directly into the abdominal cavity in aerosolized form under pressure, ensuring maximum penetration of tumor tissues while minimizing systemic toxicity.
As a leading surgical oncologist, Dr. Anadi Pachaury specializes in PIPAC, providing advanced and personalized care to patients with advanced or recurrent abdominal cancers. Patients seeking PIPAC Surgery in Dwarka and Delhi NCR benefit from his expertise in minimally invasive techniques, precise chemotherapy delivery, and comprehensive post-procedure support.
Peritoneal carcinomatosis occurs when cancer cells from primary tumors, such as those in the stomach, colon, ovaries, pancreas, or appendix, spread to the peritoneum—the thin membrane lining the abdominal cavity. These tumors are often diffuse and challenging to treat, making conventional therapies less effective.
PIPAC is particularly suitable for patients with:
By delivering chemotherapy directly into the peritoneal cavity, PIPAC allows high local drug concentration with minimal systemic exposure, significantly reducing the side effects commonly associated with intravenous chemotherapy.
PIPAC is performed using a minimally invasive laparoscopic approach. The procedure includes the following steps:
The pressurized aerosol allows chemotherapy to reach peritoneal tumors more effectively than conventional intraperitoneal or intravenous methods, improving treatment efficacy.
PIPAC offers several important advantages for patients with peritoneal carcinomatosis:
These benefits make PIPAC an excellent option for patients with advanced or recurrent peritoneal cancers who have limited treatment alternatives.
PIPAC is indicated for patients with peritoneal metastases from various primary cancers, including:
Dr. Anadi Pachauryevaluates each patient individually to determine suitability for PIPAC, considering tumor type, disease stage, previous treatments, and overall health
Prior to PIPAC, a comprehensive evaluation is essential to ensure safety and effectiveness. Dr. Anadi Pachaury conducts:
This careful preparation ensures that PIPAC is tailored to each patient’s condition and optimizes treatment outcomes.
PIPAC is performed under general anesthesia and typically takes 60–90 minutes. The key aspects include:
Patients usually experience minimal discomfort, and most can resume light activities shortly after the procedure.
Recovery after PIPAC is generally quick due to the minimally invasive approach. Dr. Pachaury emphasizes:
Proper post-procedure care is essential to maximize treatment benefits and ensure patient comfort.
PIPAC is most effective when integrated into a comprehensive multidisciplinary cancer care plan. Dr. Pachaury collaborates with:
This team-based approach ensures complete care for both cancer control and long-term quality of life.
Compared to intravenous or conventional intraperitoneal chemotherapy, PIPAC offers:
These advantages make PIPAC a valuable option for patients with advanced peritoneal metastases who have limited conventional treatment options.
Under his guidance, patients receive world-class care, compassionate support, and advanced treatment options tailored to their unique medical needs.
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) represents a breakthrough in treating peritoneal carcinomatosis, allowing precise, targeted chemotherapy delivery directly to tumor sites. Its minimally invasive nature, enhanced drug penetration, and reduced systemic side effects make it an effective option for advanced or recurrent abdominal cancers.
Under the expert care of Dr. Anadi Pachaury, patients receive PIPAC Surgery in Dwarka with meticulous preoperative planning, precise execution, and comprehensive postoperative support. This advanced treatment offers hope for extended survival, improved quality of life, and renewed confidence for patients battling peritoneal malignancies.
Early consultation, accurate assessment, and integration with a multidisciplinary care plan are key to achieving the best outcomes with PIPAC. With Dr. Pachaury’s expertise, patients can access world-class, innovative cancer care that addresses both disease management and overall well-being.